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The Medical Journal of Australia in an editorial published in the May 5 edition, sent out a 
challenge to all involved in health promotion and public health by stating “An estimated one 
million Australians at high risk may not have been receiving recommended preventive 
treatments” [1]. The writers documented the large number of high risk Australians not taking 
their antihypertensive and statin medications, but made no mention of the benefits that could 
be made by lifestyle modification, or a combination of both strategies.  
  
Prevention should not be about just taking two pills per day.  Prevention must include a 
healthy lifestyle that reduces risk factors, promotes healthy relationships and optimises 
wellbeing and longevity. The prevention of cardiovascular events needs more emphasis on 
practical public health and health promotion.  We need to remember smoking cessation, 
reduced salt intake, more fruit and vegetables and other nutrition improvements, being 
physically active, weight management and other lifestyle factors. 
 
The recently released Australian Burden of Disease Study Impact and causes of illness and 
deaths in Australia 2011, provides details of the behavioural risk factors associated with death 
and disease [2] (See Table 1).  
 
Table 1. Proportion (%) of total burden attributable to each risk factor, 2011 [2] 
Risk factor Per cent of total DALY  
Tobacco use 9.0 
High body mass 5.5 
Alcohol use 5.1 
Physical inactivity 5.0 
High blood pressure  4.9 
High blood plasma glucose 2.7 
High blood cholesterol 2.4 
 
In the AIHW report [2], the effects of nutritional causes are documented individually, but they 
comprise about one third (31.5%) of the burden of disease. Physical activity is very important 
and interacts with nutrition and the overall environment to control overweight and obesity.  
For example, lifetime of moderate intensity physical activity reduces stress, cancer and 
obesity as well as cardiovascular risk.  Physical activity is associated with a lower incidence 
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of many conditions including breast cancer, cardiovascular disease, type II diabetes mellitus, 
and a slower rate of cognitive decline [3, 4].   
 
The evidence for community wide health promotion programs is substantial.  Song and 
Giovannuchi [5] have demonstrated a substantial decline in deaths from several cancers in 
populations who are non-smokers, with a BMI of 17.5-27.5, moderate alcohol consumption 
and moderate intensity physical activity [5]. Community strategies for dietary change have 
reduced cardiovascular events and mortality [6, 7].  For the prevention of obesity the Centre for 
Disease Control (CDC) has identified the following community strategies: “1) strategies to 
promote the availability of affordable healthy food and beverages, 2) strategies to support 
healthy food and beverage choices, 3) a strategy to encourage breastfeeding, 4) strategies to 
encourage physical activity or limit sedentary activity among children and youth, 5) strategies 
to create safe communities that support physical activity.” [8].  In an editorial to mark World 
Health day 2016,  there was an emphasis on the epidemic of the pandemic of type II Diabetes 
with the Lancet advocating a program of prevention [9]. 
 
Medication prevention 
The first proposal for widespread medication of the community came from Wald and Law [10] 
who advocated the widespread use of a pill containing an antihypertensive, a statin, aspirin 
and folic acid for prevention [10].  Since then evidence has emerged that folate is ineffective in 
reducing cardiovascular events [11].  While there is some evidence for aspirin, we await the 
results of further large scale studies [12, 13]. 
 
The obvious question is why has there been so much effort to medicate the population 
without first trying a widely applied health promotion program? The evidence is that physical 
activity, good nutrition and other lifestyle interventions can achieve as much, but health 
promotion in Australia has never been adequately funded and environmental change to 
promote healthy lifestyles has been lacking, with the exception of tobacco control.  Why not 
spend funds on health promotion as well as on medical services to prescribe the medication?  
Is there something magical about waving the magic wand of “a pill a day” compared to 
lifestyle advocacy?  Perhaps society is enamoured with the way ‘THE PILL’ transformed 
society by changing reproductive health practises.  But a total healthy lifestyle program that 
includes environmental change may achieve more in the longer term [14].   
The editorial by Chow and Rodgers [15] concentrates on statins and anti-hypertensive drugs 
for the “lost” million Australians [15]. Their strategy is supported by the recently reported 
Hope Study that included men 55 years of age or older, women 65 years of age or older 
without cardiovascular disease and with at least one additional risk factor besides age, and 
women 60 years of age or older who had at least two such risk factors [16]. Death from cardio 
vascular disease or stroke was monitored for five years and was substantially lower in the 
combined therapy group (hazard ratio (HR) of 0.71; 95% CI 0.56, 0.90). 
Treatment of an entire population, though it might reduce the population event rate, may 
induce side-effects in individuals who cannot benefit from the treatment because of a low 
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absolute risk [17].  No drugs are completely free of risk. Statins are associated with an increase 
in rates of diabetes and each week general practitioners see many patients with muscle aches 
from their statin [18].  In one of the classics of observational epidemiology an earlier statin 
(now withdrawn) was found to cause an increase in strokes [19].  No medication is without 
some side effects.   In a review of why the ‘polypill’ for prevention has faded from view, 
Huffman [20] discusses the adverse events commonly experienced of elevated liver enzyme 
levels, cough, and muscle pain [20].  For hypertension, lowering of blood pressure is of 
considerable benefit [21] and can often be achieved by dietary and lifestyle changes.  However 
often lifestyle changes are neglected and then drug treatment is initiated.  In Australia the 
ACE inhibitors are the most popular anti-hypertensives prescribed and these frequently cause 
a dry hacking cough (probably 30-40%) which can cause distress to the patient until the cause 
is understood and the drug is changed.  Ace inhibitors are often combined with a thiazide 
diuretic which increases diabetes rates so there is always a possibility the client will end up a 
coughing diabetic!  
The emphasis on the ‘polypill’ has now shifted to secondary prevention as recommended in 
the MJA article [1].  There is good evidence that those who have had an adverse event, such as 
a heart attack should continue to take a pill(s) to control risk factors.  But the MJA article 
implies universal screening of blood pressure and cholesterol and then administration of a pill 
for many.  Why not a universal lifestyle prescription instead (or in addition) with adequate 
funding of health promotion services to ensure their uptake in the community? 
 
There is more than the “missing million” of the MJA to write about.  We think that the 
‘missing millions (of dollars)’ that have been cut from prevention in Australia in the last 
decade also has significant ramifications for the health of Australians [22, 23]. Health 
promotion workforce and programs have been cut across Australia [3, 24].  Epidemiologists 
have diverted their energy to research on queuing theory to optimise waiting lists for surgery 
while surveillance at the primary health level has been reduced [22] 
The cuts to prevention have diverted resources towards treatment options resulting in a short 
term oriented hospital and health policy.  In Australia, we need a commitment by all political 
parties to health promotion and prevention that will result in the continuing improvement in 
our health status.  Yes, popping a pill may be a part of the answer, but let us also regain and 
improve true prevention.    
The question for our society to decide is whether we want to promote ‘pill popping’ or a 
healthy lifestyle. The advantage of living a healthy lifestyle is that it can reduce the risks of a 
cardiovascular event as much as a pill.  At the same time it has no side effects but many other 
advantages.  Lifestyle change sometimes involves complex and difficult choices as the 
campaign against tobacco has shown.  While there is much that can be done now, long term 
lifestyle change to promote health will involve such complex areas as city planning to involve 
more activity and the control of fast food advertising and the availability of healthy food 
choices [14].  
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Australia has the options before it to either proceed down the path of personalised medicine, 
potentially a nation of pill poppers or to embrace a healthy lifestyle for the whole population.  
In an era when expenditure on prevention is declining in contrast to therapeutic medicine and 
its spinoff “the polypill” the debate that needs to be held in Australia is about the role of 
health promotion and lifestyle advocacy can play.  Of course it is not an “either or debate” as 
medications have a legitimate role to play when lifestyle change is not enough.  This journal 
is committed to promoting a larger role for health promotion in Australia.  Evidence suggests 
that it is a cost effective way of improving health while bringing a better life to Australians. 
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